Umeclidinium And Vilanterol Ellipta Powder
Product Images NDC 66993-134

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Umeclidinium And Vilanterol Ellipta (NDC 66993-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Umeclidinium Bromide Chemical Structure (Umeclidinium Vilanterol Ellipta Spl Graphic 01)

Umeclidinium Bromide Chemical Structure (Umeclidinium Vilanterol Ellipta Spl Graphic 01)
FDA Label Image

Vilanterol Trifenatate Chemical Structure (Umeclidinium Vilanterol Ellipta Spl Graphic 02)

Vilanterol Trifenatate Chemical Structure (Umeclidinium Vilanterol Ellipta Spl Graphic 02)
FDA Label Image

Figure 1 (Umeclidinium Vilanterol Ellipta Spl Graphic 03)

Figure 1 (Umeclidinium Vilanterol Ellipta Spl Graphic 03)
Population description for different characteristics such as gender, hepatic impairment, and metabolic activity with corresponding recommendations for dosage adjustments. The data includes estimates of fold change and 90% confidence intervals for these specific populations. Furthermore, details about the effect on AUC (Area Under the Curve) values for different conditions are also provided. Overall, this text addresses the impact of various factors on drug pharmacokinetics in the specified population groups.*
FDA Label Image

Figure 2 (Umeclidinium Vilanterol Ellipta Spl Graphic 04)

Figure 2 (Umeclidinium Vilanterol Ellipta Spl Graphic 04)
FDA Label Image

Figure 3 (Umeclidinium Vilanterol Ellipta Spl Graphic 05)

Figure 3 (Umeclidinium Vilanterol Ellipta Spl Graphic 05)
FDA Label Image

Figure 3 (Umeclidinium Vilanterol Ellipta Spl Graphic 06)

Figure 3 (Umeclidinium Vilanterol Ellipta Spl Graphic 06)
FDA Label Image

Figure 4 (Umeclidinium Vilanterol Ellipta Spl Graphic 07)

Figure 4 (Umeclidinium Vilanterol Ellipta Spl Graphic 07)
FDA Label Image

Figure 4 (Umeclidinium Vilanterol Ellipta Spl Graphic 08)

Figure 4 (Umeclidinium Vilanterol Ellipta Spl Graphic 08)
FDA Label Image

Figure 5 (Umeclidinium Vilanterol Ellipta Spl Graphic 09)

Figure 5 (Umeclidinium Vilanterol Ellipta Spl Graphic 09)
FDA Label Image

Figure 5 (Umeclidinium Vilanterol Ellipta Spl Graphic 10)

Figure 5 (Umeclidinium Vilanterol Ellipta Spl Graphic 10)
FDA Label Image

Umeclidinium And Vilanterol Ellipta Inhaler Parts (Umeclidinium Vilanterol Ellipta Spl Graphic 11)

Umeclidinium And Vilanterol Ellipta Inhaler Parts (Umeclidinium Vilanterol Ellipta Spl Graphic 11)
FDA Label Image

Figure A (Umeclidinium Vilanterol Ellipta Spl Graphic 12)

Figure A (Umeclidinium Vilanterol Ellipta Spl Graphic 12)
FDA Label Image

Figure B (Umeclidinium Vilanterol Ellipta Spl Graphic 13)

Figure B (Umeclidinium Vilanterol Ellipta Spl Graphic 13)
FDA Label Image

Figure C (Umeclidinium Vilanterol Ellipta Spl Graphic 14)

Figure C (Umeclidinium Vilanterol Ellipta Spl Graphic 14)
FDA Label Image

Figure D (Umeclidinium Vilanterol Ellipta Spl Graphic 15)

Figure D (Umeclidinium Vilanterol Ellipta Spl Graphic 15)
FDA Label Image

Figure E (Umeclidinium Vilanterol Ellipta Spl Graphic 16)

Figure E (Umeclidinium Vilanterol Ellipta Spl Graphic 16)
FDA Label Image

Figure F (Umeclidinium Vilanterol Ellipta Spl Graphic 17)

Figure F (Umeclidinium Vilanterol Ellipta Spl Graphic 17)
FDA Label Image

Figure G (Umeclidinium Vilanterol Ellipta Spl Graphic 18)

Figure G (Umeclidinium Vilanterol Ellipta Spl Graphic 18)
FDA Label Image

Figure H (Umeclidinium Vilanterol Ellipta Spl Graphic 19)

Figure H (Umeclidinium Vilanterol Ellipta Spl Graphic 19)
FDA Label Image

Figure I (Umeclidinium Vilanterol Ellipta Spl Graphic 20)

Figure I (Umeclidinium Vilanterol Ellipta Spl Graphic 20)
FDA Label Image

Figure J (Umeclidinium Vilanterol Ellipta Spl Graphic 21)

Figure J (Umeclidinium Vilanterol Ellipta Spl Graphic 21)
FDA Label Image

Figure K (Umeclidinium Vilanterol Ellipta Spl Graphic 22)

Figure K (Umeclidinium Vilanterol Ellipta Spl Graphic 22)
FDA Label Image

Umeclidinium And Vilanterol Ellipta 30 Dose Carton (Umeclidinium Vilanterol Ellipta Spl Graphic 23)

Umeclidinium And Vilanterol Ellipta 30 Dose Carton (Umeclidinium Vilanterol Ellipta Spl Graphic 23)
Description: This text provides information about a medication with the NDC code 66993-134-97, which is an inhalation powder containing Umeclidinium and Vilanterol. Each blister contains 62.5 mcg of Umeclidinium and 25 mcg of Vilanterol. The medication is for oral inhalation only and comes in an Ellipta inhaler with 30 doses (60 blisters total). It is Rx Only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.